- The trend backdrop is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
6617
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Gongwin Biopharm Holdings Co., Ltd. · Healthcare · Biotechnology
Latest close
101.0 TWD
4.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 31.9% above the Trend Line and sits at 69.2% of its 52-week range. The latest completed week returned 4.9%, after a -4.3% four-week move.
Setup score
43
out of 100
Latest Close
101.0 TWD
14 Aug 2026
1W Return
4.9%
latest completed week
4W Return
-4.3%
short-term follow-through
12W Return
59.1%
quarterly tape
Trend Breadth
13.5%
7 of 52 weeks active
Volume Ratio
2.6x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 34.24% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.9%
Latest completed week; four-week move -4.3%.
Indicator stack
21/68
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 34.24%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 31.9% above the Trend Line and sits at 69.2% of its 52-week range. The latest completed week returned 4.9%, after a -4.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4112-week average 0.21
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.3% over four weeks, 59.1% over 12 weeks, and -0.5% over one year. The current trend has remained active for 4 consecutive weeks.
Performance by holding period
Active trend streak4 weeks
Active weeks in one year7
Trend breadth13.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.11Latest activity-pressure read.
Pressure change-21.5%Four-week change in activity pressure.
Leadership-15.50Latest relative-leadership reading.
RS change-35.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.8%Distance below the 52-week high.
13-week volatility16.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+44.5%Week of 3 Jul.
Worst week-18.7%Week of 24 Jul.
Latest week+4.9%Week of 14 Aug.
Shape of recent returns
Strong gains7
Modest gains3
Flat weeks0
Modest losses8
Sharp losses8
Recent vol16.4%13-week weekly-return volatility.
Base vol9.9%52-week weekly-return volatility.
Up/down split19/32Count of positive and negative weeks in the 52-week window.
Average skew8.9% / -4.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank73 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank57 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape35/100
Trend, activity pressure, participation, and risk combine to a 35/100 tape read.
Indicator analysis42/100Latest 12-week confirmation: trend 4/12, activity pressure 10/12, relative leadership 0/12.
Activity pressure 0.41; No reversal markers Next-Week ExpectancyNegative 34.24%Next-week expectancy is negative with a 34.24% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 101.0 TWD | 4.9% | 76.57 TWD | 123.6 TWD | 1.11 | -15.50 | 5.8M | On |
| 7 Aug 2026 | 96.30 TWD | 26.7% | 75.85 TWD | 124.4 TWD | 1.14 | -17.77 | 2.9M | On |
| 31 Jul 2026 | 76.00 TWD | -11.4% | 75.47 TWD | 125.2 TWD | 1.30 | -34.43 | 1.8M | On |
| 24 Jul 2026 | 85.80 TWD | -18.7% | 75.82 TWD | 125.9 TWD | 1.62 | -28.16 | 2.3M | On |
| 17 Jul 2026 | 105.5 TWD | -4.1% | 75.79 TWD | 126.7 TWD | 1.42 | -11.42 | 2.3M | Off |
| 10 Jul 2026 | 110.0 TWD | 18.8% | 75.19 TWD | 127.7 TWD | 1.08 | -13.98 | 4.8M | Off |
| 3 Jul 2026 | 92.60 TWD | 44.5% | 74.15 TWD | 128.6 TWD | 0.73 | -30.47 | 2.8M | Off |
| 26 Jun 2026 | 64.10 TWD | -5.2% | 73.76 TWD | 129.7 TWD | 0.31 | -50.17 | 896.7K | Off |
| 19 Jun 2026 | 67.60 TWD | -1.7% | 74.17 TWD | 130.9 TWD | 0.48 | -50.55 | 613.1K | Off |
| 12 Jun 2026 | 68.80 TWD | 0.9% | 74.74 TWD | 132.1 TWD | 0.21 | -48.14 | 1.1M | Off |
| 5 Jun 2026 | 68.20 TWD | -5.5% | 75.59 TWD | 133.4 TWD | -0.05 | -50.75 | 958.8K | Off |
| 29 May 2026 | 72.20 TWD | 13.7% | 76.56 TWD | 134.8 TWD | -0.28 | -48.69 | 2.3M | Off |
| 22 May 2026 | 63.50 TWD | 1.9% | 77.39 TWD | 136.2 TWD | -0.34 | -53.30 | 771.0K | Off |
| 15 May 2026 | 62.30 TWD | -1.1% | 78.44 TWD | 137.6 TWD | -0.31 | -53.96 | 1.4M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.